Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
December 14, 2023 at 06:30 AM EST
Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the combination over a shorter period.
